AACR-CP: Gout Drug May Have Cancer Prevention Activity (CME/CE, with audio)
PHILADELPHIA (MedPage Today) — Levels of biomarkers associated with colon cancer declined significantly following treatment with the anti-gout drug allopurinol, although expression of the primary-endpoint marker did not change, according to a study reported here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com